ANTXR1 and prostate cancer: The identification of TEM8/ANTXR1 as a potential mediator of neuroendocrine transformation was most clearly shown in prostate cancer, where N-MYC was found to promote dysregulated angiogenesis and tumor progression via TEM8/ANTXR1 (Li et al., 2021a).